Company: GANX
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001104659-25-110347
Chunk: 23

Company: Gain Therapeutics, Inc.
Filing Date: 2025-11-12
Form: 10-Q
Item: Part II, Item 6
Chunk 23
---
​​101.SCH*​Inline XBRL Taxonomy Extension Schema Document​​​​​​​​101.CAL*​Inline XBRL Taxonomy Extension Calculation Linkbase Document​​​​​​​​101.DEF*​Inline XBRL Taxonomy Extension Definition Linkbase Document​​​​​​​​101.LAB*​Inline XBRL Taxonomy Extension Label Linkbase Document​​​​​​​​101.PRE*​Inline XBRL Taxonomy Extension Presentation Linkbase Document​​​​​​​​104*​Cover Page Interactive Data File (formatted as Inline XBRL and embedded within the iXBRL document)​​​​​​​​

*Filed herewith.

+ Management contract or compensatory plan or arrangement.

† This certification is being furnished solely to accompany this Quarterly Report pursuant to 18 U.S.C Section 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing by the registrant under the